A2E-25229-48980
2 vaccinations
11 coded responses
22 check-ins
11 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 060 / CT
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2020-12-30
Registered in v-safe
-
2020-12-30
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness, Headache — Feeling: Good · Site: Swelling · DiarrheaFree text: Back of head mild ache with mild lightheadednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-01
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-12
-
2021-01-15
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Chest discomfort — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Chest discomfortMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Good · Site: Swelling · Fever · Headache, Fatigue or tirednessFree text: Racing heartMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Palpitations — Feeling: Good · Fever · Headache, Muscle or body aches, Fatigue or tirednessFree text: PalpitationsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Nausea, Vomiting, Diarrhea, Abdominal painAdult check-in
- 2021-01-22
-
2021-01-29
Survey response — day 14, dose 2MedDRA: Headache, Nausea, Paraesthesia, Peripheral swelling, Vomiting — Feeling: Fair · Be unable to workFree text: Constant headache, tingling in both hands nauseous vomiting swelling in feet and handsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — day 21, dose 2MedDRA: Headache, Paraesthesia — Feeling: Poor · Be unable to workFree text: Continuous headaches tingling in handsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — day 28, dose 2MedDRA: Headache, Lymphadenopathy, Vision blurred — Feeling: Poor · Be unable to workFree text: Swollen glands constant headache blurred visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Survey response — day 35, dose 2MedDRA: Headache, Unevaluable event — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Headache 24/7 · Healthcare visit (other): Lots of testsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-26
Survey response — day 42, dose 2MedDRA: Headache, Paraesthesia — Feeling: Poor · Be unable to workFree text: Consistent headache daily, hands tinglingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — 3 months, dose 2MedDRA: Office visit, Paraesthesia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Tingling in my hands moved to my wrist. · Healthcare visit (other): Dr officeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-07
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2021-07-16
-
2022-01-15
Survey response — 12 months, dose 2MedDRA: Adenoidal hypertrophy, Lymphadenopathy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Enlarged adenoids and glandsMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-17
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech |
Call center
5 call center cases
3 successful · 2 priority 2/3 (triaged and no follow up)
VAERS report filed, before or during a call: 2
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Back of head mild ache with mild lightheadedness
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Chest discomfort
Systemic reaction (other): Racing heart
Systemic reaction (other): Palpitations
Release 3 — day 14, dose 2
Symptoms: Constant headache, tingling in both hands nauseous vomiting swelling in feet and hands
Release 3 — day 21, dose 2
Symptoms: Continuous headaches tingling in hands
Release 4 — day 28, dose 2
Symptoms: Swollen glands constant headache blurred vision
Release 4 — day 35, dose 2
Release 4 — day 42, dose 2
Symptoms: Consistent headache daily, hands tingling
Release 7 — 3 months, dose 2
Release 10 — 12 months, dose 2
Symptoms: Enlarged adenoids and glands
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Adenoidal hypertrophy | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Peripheral swelling | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release